Breaking News, Collaborations & Alliances

Boehringer, Sanofi Enter Strategic Contract Mfg. Pact

Sanofi gains access to capabilities to transfer and manufacture biologics

Boehringer Ingelheim and Sanofi have entered an alliance to extend Sanofi’s manufacturing capacity network for therapeutic monoclonal antibodies. Boehringer’s cell culture operations will provide contract manufacturing capacities to support the production of Sanofi’s biologics pipeline.

Under the agreement, Sanofi will have access to Boehringer’s capabilities to transfer and manufacture therapeutic monoclonal antibodies for global market supply. Initial product transfers will begin in early 2015.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters